Thomas von Briel

EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis

Christine Ardito-Abraham, Barbara M. Grüner, Kenneth K. Takeuchi et al. · Cancer Cell · 2012 · 526 citations

Medicine, Molecular Biology, Oncology +14

Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients

T. Cerny, Serge Leyvraz, Thomas von Briel et al. · Annals of Oncology · 1999 · 38 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +12

Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study

A. Schuler, J. Huser, Sabine Schmid et al. · Lung Cancer · 2023 · 18 citations

Medicine, Oncology, Pharmacology +14

Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)

Michael Mark, Beat Thürlimann, Karin Ribi et al. · Journal of bone oncology · 2019 · 17 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions

Clara Lubeseder–Martellato, Katharina Alexandrow, Ana Hidalgo‐Sastre et al. · EBioMedicine · 2016 · 16 citations · Full text

Medicine, Cell Biology, Oncology +13